Literature DB >> 35891971

Frostbite in hot climates of Central Asia: retrospective analysis of the microflora of wound and antibiotic therapy.

Babur M Shakirov1,2.   

Abstract

The problem of deep frostbites belongs to one of the most complex in surgery. Treatment of such victims is very prolonged, expensive, requiring crippling operations resulting in disability. The purpose of this present study is of etiological structure of the wound microflora and its tolerance to antibacterial preparations in patients with cold injury in the regions with warm climate of severe degree. 57 microbiological investigations of wound secretions in 38 patients with severe cold injury treated in our Burn Department of RSCUMA, Samarkand, Uzbekistan had been carried out. Microflora of wounds in patients who suffered from cold injury is characterized by polyetiology and is presented by gramnegative (49.5%) and grampositive (50.5%) microorganisms. There are Pseudomonas aeruginosa (17.9%). Among gramnegative microorganisms. In this context sensitivity to preparations owing activity to Pseudomonas aeruginosa-Ceftazidim, Ceferin and Amycacin makes 48.8%, 54.5% and 81.3% accordingly. Prevailing flora of grampositive is Staphylococcus aureus (26.3% of agents), of which 60% makes MRSA. High resistance to Ciprofloxacin (66.6%), Erythromycin (52.5%) and Lincomycin (44.4%) is noted. The investigations give evidence that ABT in patient with severe frostbites is a serious problem and needs well-ground approach in prescribing antibacterial preparations. IJBT
Copyright © 2022.

Entities:  

Keywords:  Frostbite; antibacterial preparations; microflora; wound

Year:  2022        PMID: 35891971      PMCID: PMC9301161     

Source DB:  PubMed          Journal:  Int J Burns Trauma        ISSN: 2160-2026


  10 in total

1.  A history of frostbite treatment.

Authors:  B C Paton
Journal:  Int J Circumpolar Health       Date:  2000-04       Impact factor: 1.228

2.  Treatment of bilateral hand frostbite using transcatheter arterial thrombolysis after papaverine infusion.

Authors:  Arash M Saemi; Jason M Johnson; Christopher S Morris
Journal:  Cardiovasc Intervent Radiol       Date:  2009-05-16       Impact factor: 2.740

3.  Case records of the Massachusetts General Hospital. Case 41-2009. A 16-year-old boy with hypothermia and frostbite.

Authors:  Robert L Sheridan; Mark A Goldstein; Frederick J Stoddard; T Gregory Walker
Journal:  N Engl J Med       Date:  2009-12-31       Impact factor: 91.245

Review 4.  Frostbite: prevention and initial management.

Authors:  Ken Zafren
Journal:  High Alt Med Biol       Date:  2013-03       Impact factor: 1.981

5.  Retrospective study of 70 cases of severe frostbite lesions: a proposed new classification scheme.

Authors:  E Cauchy; E Chetaille; V Marchand; B Marsigny
Journal:  Wilderness Environ Med       Date:  2001       Impact factor: 1.518

6.  Reduction of the incidence of amputation in frostbite injury with thrombolytic therapy.

Authors:  Kevin J Bruen; James R Ballard; Stephen E Morris; Amalia Cochran; Linda S Edelman; Jeffrey R Saffle
Journal:  Arch Surg       Date:  2007-06

Review 7.  Recognition and treatment of freezing and nonfreezing cold injuries.

Authors:  Benjamin J Ingram; Tyler J Raymond
Journal:  Curr Sports Med Rep       Date:  2013 Mar-Apr       Impact factor: 1.733

8.  Retrospective analysis of the ethnic origins of male British army soldiers with peripheral cold weather injury.

Authors:  J E Burgess; F Macfarlane
Journal:  J R Army Med Corps       Date:  2009-03       Impact factor: 1.285

Review 9.  Frostbite: a practical approach to hospital management.

Authors:  Charles Handford; Pauline Buxton; Katie Russell; Caitlin Ea Imray; Scott E McIntosh; Luanne Freer; Amalia Cochran; Christopher He Imray
Journal:  Extrem Physiol Med       Date:  2014-04-22

Review 10.  Use of Intra-arterial Thrombolytic Therapy for Acute Treatment of Frostbite in 62 Patients with Review of Thrombolytic Therapy in Frostbite.

Authors:  Teresa Gonzaga; Kamrun Jenabzadeh; Christopher P Anderson; William J Mohr; Frederick W Endorf; David H Ahrenholz
Journal:  J Burn Care Res       Date:  2016 Jul-Aug       Impact factor: 1.845

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.